|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 12-08-02 | Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading | RE |
| 12-07-16 | BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion | RE |
Biopharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.61% | +2.88% | +45.63% | +0.39% | 83.24B | |
| -0.69% | +3.58% | -19.85% | -35.64% | 59.49B | |
| +14.36% | +152.27% | +526.55% | +41.90% | 63.41B | |
| +0.76% | +3.53% | +0.08% | +36.18% | 52.94B | |
| -0.45% | +2.43% | +11.69% | +171.48% | 49.86B | |
| +1.21% | +3.87% | +61.90% | -16.51% | 32.62B | |
| +1.36% | +5.06% | +53.04% | +103.13% | 26.29B | |
| +9.69% | +11.76% | +14.67% | +215.97% | 22.23B | |
| -0.77% | +0.43% | +61.46% | +123.30% | 17.22B | |
| Average | +2.90% | +20.50% | +83.91% | +71.13% | 45.26B | |
| Weighted average by Cap. | +2.98% | +27.36% | +101.62% | +49.43% |
- Stock Market
- Stocks
- Stock
- Company Amylin Pharmaceuticals LLC
Select your edition
All financial news and data tailored to specific country editions
